Laila Kott
Laila Kott is senior director of CMC at Xenon, Canada. She earned her BS in chemistry from the University of Toronto, MS in chemistry from the University of Waterloo, and PhD in bioanalytical chemistry from the University of Massachusetts. Dr. Kott’s industrial experience spans from early-stage to late-stage development to post-approval commitments. She has experience working in several large pharmaceutical companies, contract analytical labs, and biotech startups. Her analytical background reflects her deep knowledge of many analytical techniques, which is echoed in her list of publications.